科学健康资讯 · 内容仅供参考,不替代专业诊疗 联系我们|疾病百科
操作系统

akebiatherapeutics(

2023-05-09 操作系统 本文链接

Akebia Therapeutics(AKBA):

Akebia Therapeutics(AKBA) 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001628280-23-007539  Act: 34  Size: 15 MB 网页链接

Akebia Therapeutics(AKBA):

Akebia Therapeutics(AKBA) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-23-002041  Size: 7 KB 网页链接

Akebia Therapeutics(AKBA):

Akebia Therapeutics(AKBA) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-23-002039  Size: 5 KB 网页链接

Akebia Therapeutics(AKBA):

Akebia Therapeutics(AKBA) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-23-002038  Size: 4 KB 网页链接

Akebia Therapeutics(AKBA):

Akebia Therapeutics(AKBA) DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-23-088046  Act: 34  Size: 24 KB 网页链接

Akebia Therapeutics(AKBA):

Akebia Therapeutics(AKBA) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-23-002200  Size: 8 KB 网页链接

Akebia Therapeutics(AKBA):

Akebia Therapeutics(AKBA) DEF 14A Other definitive proxy statements Accession Number: 0001193125-23-056298  Act: 34  Size: 751 KB 网页链接

Akebia Therapeutics(AKBA):

Akebia Therapeutics(AKBA) DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-23-080563  Act: 34  Size: 13 KB 网页链接

Akebia Therapeutics(AKBA):

Akebia Therapeutics(AKBA) DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-23-080560  Act: 34  Size: 17 KB 网页链接

Akebia Therapeutics(AKBA):

Akebia Therapeutics(AKBA) DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-23-078620  Act: 34  Size: 29 KB 网页链接

Akebia Therapeutics(AKBA):

Akebia Therapeutics(AKBA) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-23-002199  Size: 8 KB 网页链接

Akebia Therapeutics(AKBA):

Akebia Therapeutics(AKBA) 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-23-065311  Act: 34  Size: 240 KB 网页链接

Akebia Therapeutics(AKBA):

Akebia Therapeutics(AKBA) DEFR14A Revised definitive proxy soliciting materials Accession Number: 0001193125-23-073252  Act: 34  Size: 1 MB 网页链接

Akebia Therapeutics(AKBA):

Akebia Therapeutics(AKBA) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-23-002037  Size: 5 KB 网页链接

Akebia Therapeutics(AKBA):

Akebia Therapeutics(AKBA) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-23-002198  Size: 8 KB 网页链接

Akebia Therapeutics(AKBA):

Akebia Therapeutics(AKBA) 8-K Current report, item 1.01 Accession Number: 0001193125-23-058118  Act: 34  Size: 140 KB 网页链接

Akebia Therapeutics(AKBA):

Akebia Therapeutics(AKBA) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-23-002197  Size: 6 KB 网页链接

Akebia Therapeutics(AKBA):

Akebia Therapeutics(AKBA) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-23-002040  Size: 4 KB 网页链接

Akebia Therapeutics(AKBA):

Akebia Therapeutics(AKBA) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-23-002201  Size: 11 KB 网页链接

本文内容仅供健康科普参考,不能替代专业医疗诊断和治疗建议。如有身体不适,请及时就医并遵从医师指导。

相关阅读